Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment By: MarketWatch June 09, 2023 at 17:12 PM EDT If granted full FDA approval, which could come in early July, treatment could boost annual Medicare spending by nearly $9 billion, analysis shows. Read More >> Related Stocks: Biogen Idec Eisai Co. Ltd Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment By: MarketWatch June 09, 2023 at 17:12 PM EDT If granted full FDA approval, which could come in early July, treatment could boost annual Medicare spending by nearly $9 billion, analysis shows. Read More >> Related Stocks: Biogen Idec Eisai Co. Ltd